APO M250 Pill: blue & pink, capsule/oblong, 19mm
The pill with imprint APO M250 (Blue & Pink, Capsule/Oblong, 19mm) has been identified as Mycophenolate Mofetil 250 mg and is used for Organ Transplant, Rejection Prophylaxis. It belongs to the drug class selective immunosuppressants and is not a controlled substance.
Images for APO M250
Mycophenolate Mofetil
- Imprint
- APO M250
- Strength
- 250 mg
- Color
- Blue & Pink
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
gelatin,
sodium lauryl sulfate,
ferric oxide red,
titanium dioxide,
indigotindisulfonate sodium,
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia,
ferrosoferric oxide,
potassium hydroxide,
water
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-2968 (Discontinued) | Apotex Corp. |
| 68084-0587 (Discontinued) | Amerisource Health Services |
Related images for "APO M250"
More about mycophenolate mofetil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (60)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Mycophenolate mofetil oral/injection drug information
- Mycophenolate (Intravenous) (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Other brands
Professional resources
- Mycophenolate monograph
- Mycophenolate (FDA)
- Mycophenolate Mofetil (FDA)
- Mycophenolate Mofetil Injection (FDA)
- Mycophenolate Suspension (FDA)
- Mycophenolate Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.